Related Experiment Video
Updated: May 10, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative
Mohammad Reza Bazavar1, Hamed Helali1, Linda Mohammadzadeh Boukani2
1Department of Orthopedic Surgery, School of Medicine and Shohada Educational Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Our current research aims to investigate how Resveratrol influences DOX-induced apoptosis in Saos-2 cells resulting from DNA damage.Saos-2 cells were cultured with DOX, and an MTT assay was conducted to evaluate cell viability. The expression levels of DNA damage markers were evaluated using qRT-PCR and western blotting methods. Apoptosis was also investigated by flow cytometry.In a dose-dependent way, DOX produced a profuse suppression of cell proliferation. This study investigates the effect of Resveratrol on DOX-induced apoptosis due to DNA damage in Saos-2 cells (P<0.05). There was an increase in H2AX, ATR, ATM, Rad51, and p53 expression, possibly contributing to subsequent apoptosis. Furthermore, Resv enhanced the apoptosis caused by DOX in Saos-2 cells.The findings from the current research provide an understanding of how Resv plays a role in potentially treating osteosarcoma by enhancing DOX-induced apoptosis.
Insights
Resveratrol enhances doxorubicin-induced apoptosis in Saos-2 cells by increasing DNA damage markers. This suggests Resveratrol may aid osteosarcoma treatment by boosting chemotherapy effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Doxorubicin (DOX) is a chemotherapy agent used to treat osteosarcoma.
- DOX-induced DNA damage can lead to apoptosis in cancer cells.
- Resveratrol (Resv) is a natural polyphenol with potential anti-cancer properties.
Purpose of the Study:
- To investigate the effect of Resveratrol on doxorubicin-induced apoptosis in Saos-2 osteosarcoma cells.
- To determine if Resveratrol influences DNA damage pathways activated by doxorubicin.
Main Methods:
- Saos-2 cells were treated with DOX and Resveratrol.
- Cell viability was assessed using MTT assay.
- DNA damage markers (H2AX, ATR, ATM, Rad51, p53) were quantified by qRT-PCR and Western blotting.
- Apoptosis was analyzed via flow cytometry.
Main Results:
- Doxorubicin significantly suppressed Saos-2 cell proliferation in a dose-dependent manner.
- Resveratrol enhanced DOX-induced apoptosis in Saos-2 cells (P<0.05).
- Expression of DNA damage markers H2AX, ATR, ATM, Rad51, and p53 increased, potentially mediating apoptosis.
Conclusions:
- Resveratrol potentiates doxorubicin-induced apoptosis in Saos-2 cells.
- The findings suggest Resveratrol may enhance the efficacy of doxorubicin in osteosarcoma treatment.
- Resveratrol's role in modulating DNA damage response pathways warrants further investigation for therapeutic applications.
Related Concept Videos
Treatment Resistant Cancers
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
DNA Damage can Stall the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

